Literature DB >> 6156167

Immunological determinants of proteoglycans. Antibodies against the unsaturated oligosaccharide products of chondroitinase ABC-digested cartilage proteoglycans.

J E Christner, B Caterson, J R Baker.   

Abstract

Bovine nasal cartilage proteoglycan monomer which had been digested with chondroitinase ABC to form the keratan sulfate-protein core was injected into rabbits. High titer antiserum was obtained as judged by the binding of 125I-labeled keratan sulfate-protein core. Native proteoglycan did not inhibit the interaction of the antiserum with labeled keratan sulfate-protein core. However, the disaccharide obtained from chondroitin 4-sulfate by the action of chondroitinase ABC, 2-acetamido-2-deoxy-3-O-(beta-D-gluco-4-enepyranosyluronic acid)-4-O-sulfo-D-galactose, inhibited the interaction 50% at a concentration of 500 microM. The corresponding 6-sulfated and nonsulfated disaccharides at the same concentration gave 15% and 10% inhibition, respectively. Chondroitinase-digested proteoglycan from Swarm rat chondrosarcoma was strongly inhibitory, while the hyaluronidase-digested chondrosarcoma proteoglycan exhibited no detectable inhibition. Evidently, the antiserum raised against chondroitinase ABC-digested bovine nasal cartilage proteoglycan contains antibodies which recognize the unsaturated uronic acid residue linked to N-acetylgalactosamine 4-sulfate. These antibodies will be valuable for identifying and quantitating chondroitin 4-sulfate-containing proteoglycans in tissues.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6156167

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  28 in total

1.  Studies of a monoclonal antibody to skeletal keratan sulphate. Importance of antibody valency.

Authors:  A R Poole; C Webber; A Reiner; P J Roughley
Journal:  Biochem J       Date:  1989-06-15       Impact factor: 3.857

2.  Ultrastructural localisation of anionic sites at the dermo-epidermal junction in normal human skin.

Authors:  J Nanchahal; D J Riches
Journal:  J Anat       Date:  1991-06       Impact factor: 2.610

3.  Monoclonal antibodies to different protein-related epitopes of human articular cartilage proteoglycans.

Authors:  T T Glant; K Mikecz; A R Poole
Journal:  Biochem J       Date:  1986-02-15       Impact factor: 3.857

4.  Spatiotemporal Expression of 3-B-3(-) and 7-D-4 Chondroitin Sulfation, Tissue Remodeling, and Attempted Repair in an Ovine Model of Intervertebral Disc Degeneration.

Authors:  Brooke Farrugia; Susan M Smith; Cindy C Shu; James Melrose
Journal:  Cartilage       Date:  2019-10-03       Impact factor: 4.634

5.  Immunodiffusion studies of the tryptic fragments of bovine nasal-cartilage proteoglycan monomer of high buoyant density.

Authors:  H D Keiser
Journal:  Biochem J       Date:  1982-06-01       Impact factor: 3.857

6.  Role of carbohydrate as an antigenic determinant of a glycoprotein from rye-grass (Lolium perenne) pollen.

Authors:  B J Howlett; A E Clarke
Journal:  Biochem J       Date:  1981-09-01       Impact factor: 3.857

7.  Renal localization of heparan sulfate proteoglycan by immunohistochemistry.

Authors:  D J Klein; T R Oegema; R Eisenstein; L Furcht; A F Michael; D M Brown
Journal:  Am J Pathol       Date:  1983-06       Impact factor: 4.307

8.  Identification of a hyaluronic acid-binding protein that interferes with the preparation of high-buoyant-density proteoglycan aggregates from adult human articular cartilage.

Authors:  P J Roughley; R J White; A R Poole
Journal:  Biochem J       Date:  1985-10-01       Impact factor: 3.857

9.  Spectrophotometric measurement of proteoglycans in osteoarthritic synovial fluid.

Authors:  G J Carroll
Journal:  Ann Rheum Dis       Date:  1987-05       Impact factor: 19.103

10.  Biglycan and fibromodulin fragmentation correlates with temporal and spatial annular remodelling in experimentally injured ovine intervertebral discs.

Authors:  James Melrose; Susan M Smith; Emily S Fuller; Allan A Young; Peter J Roughley; Andrew Dart; Christopher B Little
Journal:  Eur Spine J       Date:  2007-09-25       Impact factor: 3.134

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.